These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14618266)
41. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts. Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372 [TBL] [Abstract][Full Text] [Related]
42. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260 [TBL] [Abstract][Full Text] [Related]
43. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure. Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957 [TBL] [Abstract][Full Text] [Related]
44. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Zhou J; Xu X; Liu JJ; Lin YX; Gao GD Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376 [TBL] [Abstract][Full Text] [Related]
45. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806 [TBL] [Abstract][Full Text] [Related]
46. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273 [TBL] [Abstract][Full Text] [Related]
47. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy. Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924 [TBL] [Abstract][Full Text] [Related]
53. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889 [TBL] [Abstract][Full Text] [Related]
54. [Effects of tramadol hydrochloride preconditioning on the activation of nuclear factor-ΚB induced by norepinephrine in cultured neonatal rat cardiomyocytes]. Lü ZG; Guo Z Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):646-9. PubMed ID: 24225208 [TBL] [Abstract][Full Text] [Related]
55. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. Nelson TJ; Balza R; Xiao Q; Misra RP J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986 [TBL] [Abstract][Full Text] [Related]
56. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure. Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679 [TBL] [Abstract][Full Text] [Related]
57. A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces. Jain A; Ravi V; Muhamed J; Chatterjee K; Sundaresan NR Int J Cardiol; 2017 Apr; 232():160-170. PubMed ID: 28096043 [TBL] [Abstract][Full Text] [Related]
58. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation. Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734 [TBL] [Abstract][Full Text] [Related]
59. Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients. Zhang C; Shan XL; Liao YL; Zhao P; Guo W; Wei HC; Lu R BMC Complement Altern Med; 2014 Dec; 14():474. PubMed ID: 25488774 [TBL] [Abstract][Full Text] [Related]
60. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes. Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]